Factors that lead to the use of crack cocaine in combination with marijuana in Brazil: A qualitative study Health behavior, health promotion and society

BMC Public Health

Volumn 15, Issue 1, 2015, Pages

  Goncąlves, Janaina R ^a   Nappo, Solange A ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Brazil; Cannabis; Crack cocaine; Crack cocaine and cannabis association

Indexed keywords

CANNABIS; COCAINE;

ADULT; BEHAVIOR, ADDICTIVE; BRAZIL; CANNABIS SMOKING; COCAINE-RELATED DISORDERS; COMORBIDITY; FEMALE; HUMAN; MALE; PSYCHOLOGY; QUALITATIVE RESEARCH; VIOLENCE;

ADULT; BEHAVIOR, ADDICTIVE; BRAZIL; CANNABIS; COCAINE-RELATED DISORDERS; COMORBIDITY; CRACK COCAINE; DANGEROUS BEHAVIOR; FEMALE; HUMANS; MALE; MARIJUANA SMOKING; QUALITATIVE RESEARCH;

EID: 84937772965     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-015-2063-0     Document Type: Article

References (45)

1. Dunn J, Laranjeira RR, Da Silveira DX, Formigoni ML, Ferri CP. Crack cocaine: an increase in use among patients attending clinics in Saõ Paulo: 1990-1993. Substance Use Misuse. 1996;31:519-27.
2. Inciardi JA. In: Monteiro MG, Inciardi JA, editors. Brazil-United States. Binational Research. São Paulo: CEBRID a- Centro Brasileiro de InformaçÃμ es sobre Drogas PsicotrÃpicas; 1993. p. 63a-75.
3. Grangeiro A, Silva LL, Teixeira PR. Resposta à AIDS no Brasil: contribuições dos movimentos sociais e da reforma sanitaria. Pan Am J Public Health. 2009;26(1):87-94.
4. Bastos FI, Szwarcwald CL. AIDS and pauperization: principal concepts and empirical evidence. Cad Saúde Pública. 2000;16(1):65-76.
5. Fonseca EM, Nunn A, Souza-Junior PB, Bastos FI, Ribeiro JM. Descentralization, AIDS, and harm reduction: the implementation of public policies in Rio de Janeiro Brazil. Cad Saúde Pública. 2007;23(9):2134-44.
6. Nappo SA, Galduróz JCF, Noto AR. Crack use in Saõ Paulo. Substance Use & Misuse. 1996;31(5):565-79.
7. Oliveira LG, Nappo SA. Characterization of the crack cocaine culture in the city of Saõ Paulo: a controlled patterned of use. Rev Saude Publica. 2008;42(4):664.-71, 2008.
8. Mesquita F, Kral A, Reingold A, Bueno R, Trigueiros D, Araujo PJ, et al. Trends of HIV infection among injection drug users in Brazil in the 1990s: the impact of changes in patterns of drug use. J Acquir Immune Defic Syndr. 2001;28(3):298-302.
9. Raupp L, Adorno RCF. Crack usage circuits in the downtown area of the city of Saõ Paulo (SP, Brazil). Ciência & Saúde Coletiva. 2011;16(5):2613-22.
10. Dias AC, Ribeiro MA, Dunn J, Sesso R, Laranjeira R. Mortality rate among crack/cocaine-dependent patients: A 12-year prospective cohort study conducted in Brazil. J Subst Abuse Treat. 2011;4(3):273-8.
11. Fischer B, Coghlan M. Crack use in North American cities: the neglected "epidemic". Addiction. 2007;102:1340-1.
12. Malta M, Monteiro S, Lima RMJ, Bauken S, Marco A, Zuin G, et al. HIV/AIDS risk among female sex workers who use crack in Southern Brazil. Rev Saude Publica. 2008;42(5):830-7.
13. Chen CY, Lin KM. Health consequences of illegal drug use. Curr Opin Psychiatry. 2009;22:287-92.
14. Nappo SA, Sanchez ZM, Oliveira LG. Crack, AIDS, and Women in Saõ Paulo. Brazil Subst Use Misuse. 2011;46(4):476-85.
15. Ribeiro LA, Sanchez ZM, Nappo SA. Surviving crack: a qualitative study of the strategies and tatics developed by Brazilian users to deal with the risks associated. BMC Public Health. 2010;10:671.
16. Chaves TV, Sanchez ZM, Ribeiro LA, Nappo SA. Crack cocaine craving: behaviors and coping strategies among current and former users. Rev Saude Publica. 2011;45(6):1168-75.
17. Andrade T, Santiago L, Amari E, Fischer B: "What a pity"-exploring the use of "pitilho" as harm reduction among crack users in Salvador, Brazil. Drug: Education, Prevention and Policy 2010, 1-3, online.
18. World Health Organization. Qualitative research for health programs. Geneva: Division of Mental Health; 1994
19. Taylor SJ, Bogdan R. Introduction to Qualitative Research Methods. New York: John Wiley & Sons Inc; 1998.
20. Patton M. Qualitative research and evaluation methods. 3rd ed. Thousand Oaks: Sage Publications; 2002.
21. Pope C, Ziebland S, Mays N. Analysing qualitative data. Br Med J. 2000;320:114-6.
22. Kvale S. InterViews: an introduction to qualitative research interviewing. Thousand Oaks: Sage Publications; 1996.
23. Creswell JW: Research design: Qualitative, quantitative and mixed methods approaches. 3rd edition: London: Sage Publications; 2009.
24. Siegel RK. Cocaine smoking. J Psychoactive Drugs. 1982;4(4):271-359.
25. Biernacki P, Waldorf D. Snowball sampling: problems and techniques of chain referral sampling. Sociol Methods Res. 1981;10(2):141-63.
26. ABEP (Associação Brasileira de Empresas e Pesquisa). Critério de Classificação EconÃmica Brasil. 2012.
27. th edition.Washington DC: American Psychiatric Publishing
28. Bardin L. AnÃilise de Conteðdo, vol. 70. 3rd ed. Lisboa: EdiçÃμ es; 2004.
29. Labigalini E, Rodrigues LR, Silveira DX. Therapeutic use of cannabis by crack addicts in Brazil. J Psychoactive Drugs. 1999;31(4):451-5.
30. SENAD-National Office on Drug Policy: [ http://www.obid.senad.gov.br/portais/OBID/index.php[ (accessed on March 05, 2015).
31. Vaughn MG, Perron BE, Bohnert AS, Howard MO. Is crack cocaine use associated with greater violence than powdered cocaine use? Results from a national sample. Am J Drug Alcohol Abuse. 2010;36(4):181-6.
32. Pinheiro RT, Kapczinski F, Silva RA, Pechansky F, Magalhães PV. Violent and sexual behaviors and lifetime use of crack cocaine: a population-based study in Brazil. Soc Psychiatr Epidemiol. 2014;49(8):1249-55.
33. Cruz M, Bertoni N, Bastos FI, Burnett C, Gooch J, Fisher B. Comparing key characteristics of young adult crack users in and out-of-treatment in Rio de Janeiro, Brazil. Subst Abuse Treat Prev Policy. 2014;9:2.
34. Carlini EA. The good and the bad effects of (2) trans-delta-9-tetrahydrocannabinol (D9-THC) on humans. Toxicon. 2004;44:461-7.
35. Zuardi AW. History of cannabis as a medicine: a review. Rev Bras Psiquiatr. 2006;28(2):153-7.
36. Carlini EA, Cunha JM. Hypnotic and antiepileptic effects of cannabidiol. J Clin Pharmacol. 1981;21(8-9):417S-27.
37. Leite JR, Carlini EA, Lander N, Mechoulan R. Anticonvulsant effects of the (-) and (+) isomers of cannabidiol and their dimethylheptyl homologs. Pharmacology. 1982;24(3):141-6.
38. Webb CW, Webb SM. Therapeutic benefits of Cannabis: A patient survey. Hawaii J Med Public Health. 2014;73(4):109-11.
39. Brunt TM, van Genugten M, Höner-Snoeken K, van de Velde MJ, Niesink RJ. Therapeutic satisfaction and subjective effects of different strains of pharmaceutical-grade cannabis. J Clin Psychopharmacol. 2014;34(3):344-9.
40. Zuardi AW. Cannabidiol: from an inactive cannabinoid to a drug with spectrum of action. Rev Bras Psiquiatr. 2008;30(3):271-80.
41. Robson PJ, Guy GW, Di Marzo V. Cannabinoids and Schizophrenia: Therapeutic Prospects. Current Pharm Des. 2014;20(13):2194-204.
42. Schubart CD, Sommer IE, van Gastel WA, Goetgebuer RL, Kahn RS, Boks MP. Cannabis with high cannabidiol content is associated with fewer psychotic experiences. Schizophr Res. 2011;130(1-3):216-21.
43. Gorelick DA, Goodwin RS, Schwilke E, Schroeder JR, Schwope DM, Kelly DL, et al. Around-the-clock oral THC effects on sleep in male chronic daily cannabis smokers. Am J Addict. 2013;22(5):510-4.
44. ANVISA Portaria 344. Thecnical regulation on psychotropic drugs. May, 1998. [ http://www.anvisa.gov.br/areas/coges/legislacao/1998/PRT-344-1998-COMP.pdf[ (accessed on March 14, 2015).
45. Fiori M. The place of the state on the issue of drugs: the prohibitionist paradigm and the alternative. Novos estudos CEBRAP. 2012;92:9-21.